Table 3.
Univariate analysis for utilization of prostate MRI and MR Targeted Biopsy. OR, odds ratio; CI, 95% confidence interval
| Variable | Use of MRI | Use of MR Targeted Biopsy | ||
|---|---|---|---|---|
| Univariate OR [CI] | P value | Univariate OR [CI] | P value | |
| Age | 0.99 [.96 – 1.02] | 0.521 | 0.99 [.98–1.02] | 0.712 |
| Practice Type | ||||
| Non-academic (reference) | 1 | - | 1 | - |
| Academic | 1.09 [.55–2.18] | 0.799 | 2.06 [1.25–3.40] | 0.005 |
| Society response | ||||
| ES + EAU (reference) | 1 | - | 1 | - |
| SUO | 1.26 [.63–2.53] | 0.521 | 1.86 [1.11–3.11] | 0.018 |
| Fellowship trained | 2.14 [1.08–4.23] | 0.029 | 2.04 [1.26–3.31] | 0.004 |
| No. Prostate Biopsies per month | ||||
| 0–5 (reference) | 1 | - | 1 | - |
| 6–15 | 2.32 [1.10–4.89] | 0.027 | 1.97 [1.13–3.43] | 0.016 |
| >15 | 3.62 [1.37–9.55] | 0.009 | 4.12 [2.09–8.13] | <0.001 |
| No. of RARPs per year | ||||
| 0–25 (reference) | 1 | - | 1 | - |
| 26–75 | 2.25 [1.01–5.02] | 0.047 | 3.08 [1.75–5.44] | <0.001 |
| >75 | 3.32 [1.11–9.93] | 0.032 | 5.26 [2.47–11.18] | <0.001 |